Year: 2008
Type: article
Study design: Case Report
Abstract: Pseudoephedrine is a sympathomimetic agent found in pharmacologic preparations used as nasal decongestants. Cutaneous adverse reactions attributed to pseudoephedrine are rare despite extensive use. Generalized dermatitis, pigmented purpuric dermatosis, toxic epidermal necrolysis, fixed eruption, and generalized scarlatiniform or eczematous eruptions have been reported.1,2 We report a typical case of acute generalized exanthematous pustulosis (AGEP) associated with this sympathomimetic drug. A 31-year-old woman was admitted to hospital with a generalized pustular eruption 2 days after starting self-medication with paracetamol/pseudoephedrine for rhinitis. She had no personal history of drug allergy or psoriasis. On examination, a widespread symmetric erythematous eruption, with numerous nonfollicular pinpoint pustules over the trunk (Fig. 1) and proximal limbs, was observed. There was no mucosal involvement. The patient was febrile (39.5 °C). Blood analysis showed a raised white blood cell count of 25.6 × 109/L, with a neutrophil count of 22.2 × 109/L and normal eosinophilia. All blood biochemistry results were normal. Blood culture was negative, as was serology for cytomegalovirus and Epstein–Barr virus. There was no evidence of Staphylococcus aureus in the pustules. A biopsy of the involved skin showed subcorneal and intraepidermal spongiform pustules and some single scattered necrolytic keratinocytes. The superficial dermis was edematous, with mixed inflammatory infiltration, including numerous neutrophils and eosinophils, without evidence of leukocytoclastic vasculitis (Fig. 2). Based on the clinicopathologic features, AGEP secondary to paracetamol/pseudoephedrine was diagnosed. After discontinuation of the medication, the patient became afebrile within 2 days and the acute eruption dramatically improved within 4 days, followed by postinflammatory desquamation. Oral provocation by paracetamol, which is routinely used by the patient, was performed. Rechallenge by paracetamol, even at therapeutic doses, 4 months later caused no skin eruption. This rules out the pathogenic role of paracetamol. According to the objective causality assessment by the Naranjo probability scale, pseudoephedrine-induced AGEP was probable.3 The patient was firmly instructed to ovoid self-medication, particularly with pseudoephedrine. Diffuse erythema with numerous pinpoint pustules on the trunk Skin biopsy (hematoxylin and eosin, ×100). Subcorneal spongiform pustule with neutrophils (arrow). Inset (lower left; hematoxylin and eosin, ×400) shows the presence of necrolytic keratinocytes (large arrow) and eosinophils (small arrow) Drugs are incriminated in more than 90% of cases of AGEP. Medications from many different pharmacologic classes, especially antibiotics, have been suspected in the development of AGEP. Infections with human parvovirus B19, cytomegalovirus, and Epstein–Barr virus, as well as brown recluse spider bites, can also trigger AGEP. Lymphocytic transformation testing and epicutaneous testing can be useful for diagnostic confirmation. To our knowledge, only two well-documented cases of AGEP have been reported with pseudoephedrine in the English literature.4,5 Pseudoephedrine is usually present in multicompound products and is widely used in over-the-counter medications. Therefore, it should be considered when evaluating the history of drug exposure in a patient with adverse drug reaction.
Language: English
Subfield: Pharmacology (medical)
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W2016006038
